Advertisement

Topics

J&J seals deal on purchase of major diabetes devices firm

08:40 EDT 14 Jun 2018 | pharmaphorum

A deal worth $2.1 billion has been struck between Johnson & Johnson (J&J) and the firm behind the world-leading glucose monitoring system. Platinum Equity, whose business LifeScan Inc makes the OneTouch devices, made the binding offer to J...

Original Article: J&J seals deal on purchase of major diabetes devices firm

NEXT ARTICLE

More From BioPortfolio on "J&J seals deal on purchase of major diabetes devices firm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...